Salbutamol increases tristetraprolin expression in macrophages

Life Sciences

Volumn 81, Issue 25-26, 2007, Pages 1651-1658

  Jalonen, Ulla ^a   Leppänen, Tiina ^a   Kankaanranta, Hannu ^a   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

2 agonist; Activator protein 2; Asthma; cAMP; Inflammation; Salbutamol; Tristetraprolin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; ROLIPRAM; SALBUTAMOL; TERBUTALINE; TRANSCRIPTION FACTOR AP 2; TRISTETRAPROLIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALBUTEROL; ANIMALS; BLOTTING, NORTHERN; BUCLADESINE; FORSKOLIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MICE; RNA STABILITY; RNA-BINDING PROTEINS; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 36448996619     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.022     Document Type: Article

References (41)

1. 2-agonists: inhibition of TNF-α release from human mast cells. The Journal of Allergy and Clinical Immunology 100 6 Pt 1 (1997) 825-831
2. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochemical Society Transactions 30 Pt 6 (2002) 945-952
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
4. Broadley K.J. β-Adrenoceptor responses of the airways: for better or worse?. European Journal of Pharmacology 533 1-3 (2006) 15-27
5. Cao H., Tuttle J.S., and Blackshear P.J. Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein. Journal of Biological Chemistry 279 20 (2004) 21489-21499
6. Cao H., Kelly M.A., Kari F., Dawson H.D., Urban Jr. J.F., Coves S., Roussel A.M., and Anderson R.A. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. Journal of Inflammation (London, England) 4 1 (2007) 12 pages
7. Cao H., Polansky M.M., and Anderson R.A. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Archives of Biochemistry and Biophysics 459 2 (2007) 214-222
8. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281 5379 (1998) 1001-1005
9. Carballo E., Lai W.S., and Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95 6 (2000) 1891-1899
10. DuBois R.N., McLane M.W., Ryder K., Lau L.F., and Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. Journal of Biological Chemistry 265 31 (1990) 19185-19191
11. 2-adrenoceptor signalling in the airways. The European Respiratory Journal 27 6 (2006) 1286-1306
12. 1 switch gene homologous to a rodent gene encoding a zinc-binding potential transcription factor. DNA and Cell Biology 12 1 (1993) 73-88
13. Imagawa M., Chiu R., and Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 2 (1987) 251-260
14. Izeboud C.A., Monshouwer M., van Miert A.S.J.P.A.M., and Witkamp R.F. The β-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-α and IL-6 in vitro and in vivo. Inflammation Research 48 9 (1999) 497-502
15. Jalonen U., Lahti A., Korhonen R., Kankaanranta H., and Moilanen E. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochemical Pharmacology 69 5 (2005) 733-740
16. Jalonen U., Nieminen R., Vuolteenaho K., Kankaanranta H., and Moilanen E. Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3α synthesis in activated macrophages. Mediators of Inflammation 2006 (2006) (Article ID 40691), 8 pages
17. 2-agonists on resident and infiltrating inflammatory cells. The Journal of Allergy and Clinical Immunology 110 6 Suppl (2002) S282-S290
18. 2-adrenergic receptor function, response, and regulation. The Journal of Allergy and Clinical Immunology 117 1 (2006) 18-24
19. Kaneda N., Oshima M., Chung S.Y., and Guroff G. Sequence of a rat TIS11 cDNA, an immediate early gene induced by growth factors and phorbol esters. Gene 118 2 (1992) 289-291
20. Kaneda N., Murata T., Niimi Y., and Minamiyama M. Cloning and characterization of the rat TIS11 gene. Molecular and Cellular Biochemistry 213 1-2 (2000) 119-126
21. Lai W.S., and Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. Journal of Biological Chemistry 276 25 (2001) 23144-23154
22. Lai W.S., Stumpo D.J., and Blackshear P.J. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. Journal of Biological Chemistry 265 27 (1990) 16556-16563
23. Lai W.S., Thompson M.J., Taylor G.A., Liu Y., and Blackshear P.J. Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. Journal of Biological Chemistry 270 42 (1995) 25266-25272
24. Lai W.S., Thompson M.J., and Blackshear P.J. Characteristics of the intron involvement in the mitogen-induced expression of Zfp-36. Journal of Biological Chemistry 273 1 (1998) 506-517
25. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., and Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Molecular and Cellular Biology 19 6 (1999) 4311-4323
26. Lai W.S., Parker J.S., Grissom S.F., Stumpo D.J., and Blackshear P.J. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Molecular and Cellular Biology 26 24 (2006) 9196-9208
27. Ma Q., and Herschman H.R. A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene 6 7 (1991) 1277-1278
28. Mazina O.M., Phillips M.A., Williams T., Vines C.A., Cherr G.N., and Rice R.H. Redistribution of transcription factor AP-2α in differentiating cultured human epidermal cells. The Journal of Investigative Dermatology 117 4 (2001) 864-870
29. Mukhopadhyay S., Hoidal J.R., and Mukherjee T.K. Role of TNFα in pulmonary pathophysiology. Respiratory Research 7 125 (2006) 9 pages
30. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., and Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. Journal of Immunology 174 2 (2005) 953-961
31. Phillips K., Kedersha N., Shen L., Blackshear P.J., and Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor α, cyclooxygenase 2, and inflammatory arthritis. Proceedings of the National Academy of Sciences of the United States of America 101 7 (2004) 2011-2016
32. Ritz S.A., Stämpfli M.R., Davies D.E., Holgate S.T., and Jordana M. On the generation of allergic airway diseases: from GM-CSF to Kyoto. Trends in Immunology 23 8 (2002) 396-402
33. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Müller M., Blackshear P.J., and Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 107 12 (2006) 4790-4797
34. Sawaoka H., Dixon D.A., Oates J.A., and Boutaud O. Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. Journal of Biological Chemistry 278 16 (2003) 13928-13935
35. 2-adrenergic receptors in inflammation and allergy. Current Drug Targets - Inflammation and Allergy 4 2 (2005) 157-162
36. Smoak K., and Cidlowski J.A. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Molecular and Cellular Biology 26 23 (2006) 9126-9135
37. Stoecklin G., Ming X.-F., Looser R., and Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Molecular & Cellular Biology 20 11 (2000) 3753-3763
38. Stoecklin G., Stoeckle P., Lu M., Muehlemann O., and Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7 11 (2001) 1578-1588
39. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., and Blackshear P.J. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 5 (1996) 445-454
40. Varnum B.C., Lim R.W., Sukhatme V.P., and Herschman H.R. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 4 1 (1989) 119-120
41. Yu H., Stasinopoulos S., Leedman P., and Medcalf R.L. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. Journal of Biological Chemistry 278 16 (2003) 13912-13918